Approved for marketing [clinicaltrials_resource:e02b6bf0f9e757968e0eb58303d13587]
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma. [clinicaltrials:NCT00040625]An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options [clinicaltrials:NCT00042393]Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease [clinicaltrials:NCT00074919]A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 [clinicaltrials:NCT00094029]Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00130897]TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens. [clinicaltrials:NCT00245739]Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization [clinicaltrials:NCT00291811]Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease [clinicaltrials:NCT00293098]Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection [clinicaltrials:NCT00338442]Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023) [clinicaltrials:NCT00377065]The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol [clinicaltrials:NCT00438789]Korean Early Access Program [clinicaltrials:NCT00454753]Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity [clinicaltrials:NCT00481559]Sapropterin Expanded Access Program [clinicaltrials:NCT00484991]Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection [clinicaltrials:NCT00499720]Alglucosidase Alfa Temporary Access Program [clinicaltrials:NCT00520143]Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System [clinicaltrials:NCT00528320]Humanitarian Device Exemption [clinicaltrials:NCT00580658]Emergency/Compassionate Use - Muscular VSD Occluder [clinicaltrials:NCT00590382]Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis [clinicaltrials:NCT00649545]Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis [clinicaltrials:NCT00650026]Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab [clinicaltrials:NCT00650390]A Belatacept Compassionate Use Study for Patients With a Kidney Transplant [clinicaltrials:NCT00719225]Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma [clinicaltrials:NCT00730444]SynCardia Freedom Driver System Study [clinicaltrials:NCT00733447]A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 [clinicaltrials:NCT00786058]Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant [clinicaltrials:NCT00811525]Prometra's Utilization in Mitigating Pain II [clinicaltrials:NCT00866164]Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase [clinicaltrials:NCT00905593]Mentor Adjunct Study for Silicone Gel-Filled Mammary Prosthesis [clinicaltrials:NCT00948948]Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease [clinicaltrials:NCT00954460]Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis [clinicaltrials:NCT00989807]A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer [clinicaltrials:NCT01120561]A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma [clinicaltrials:NCT01160250]An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory [clinicaltrials:NCT01240421]Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device Under a Continued Access Protocol [clinicaltrials:NCT01242891]Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft [clinicaltrials:NCT01327742]VX-770 Expanded Access Program [clinicaltrials:NCT01381289]Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease [clinicaltrials:NCT01410500]Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis [clinicaltrials:NCT01579890]
overall status [clinicaltrials_vocabulary:overall-status]
Approved for marketing [clinicaltrials_resource:e02b6bf0f9e757968e0eb58303d13587]
Bio2RDF identifier
e02b6bf0f9e757968e0eb58303d13587
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e02b6bf0f9e757968e0eb58303d13587
identifier
clinicaltrials_resource:e02b6bf0f9e757968e0eb58303d13587
title
Approved for marketing
@en
type
label
Approved for marketing [clinicaltrials_resource:e02b6bf0f9e757968e0eb58303d13587]
@en